Literature DB >> 28232455

Intestinal phosphate absorption is mediated by multiple transport systems in rats.

Eduardo Candeal1, Yupanqui A Caldas1,2, Natalia Guillén1, Moshe Levi2, Víctor Sorribas3.   

Abstract

Apical inorganic phosphate (Pi) transport in the small intestine seems to be mainly mediated by the sodium/Pi cotransporter NaPi2b. To verify this role, we have studied the combined effects of pH, phosphonoformate, and Pi deprivation on intestinal Pi transport. Rats were fed, ad libitum, three fodders containing 1.2, 0.6, or 0.1% Pi for 1, 5, or 10 days. Pi deprivation (0.1%) increased both sodium-activated and sodium-independent Pi transport in brush-border membrane vesicles from the duodenum and jejunum for all three times. Alkaline pH inhibited Pi transport, despite the increasing concentration of [Formula: see text] (NaPi2b substrate), whereas acidity increased transport when the concentration of the PiT1/PiT2 substrate, [Formula: see text], was at its highest. The effect of Pi deprivation was maximal at acid pH, but both basal and upregulated transport were inhibited (70%) with phosphonoformate, an inhibitor of NaPi2b. PiT2 and NaPi2b protein abundance increased after 24 h of Pi deprivation in the duodenum, jejunum, and ileum, whereas PiT1 required 5-10 days in the duodenum and jejunum. Therefore, whereas transporter expressions are partially correlated with Pi transport adaptation, the pH effect precludes NaPi2b, and phosphonoformic acid precludes PiT1 and PiT2 as the main transporters. Transport and transporter expression were also inconsistent when feeding was limited to 4 h daily, because the 1.2% Pi diet paradoxically increased Pi transport in the duodenum and jejunum, but NaPi2b and PiT1 expressions only increased with the 0.1% diet. These findings suggest the presence of a major transporter that carries [Formula: see text] and is inhibited by phosphonoformate.NEW & NOTEWORTHY The combined effects of dietary inorganic phosphate (Pi) content, pH, and phosphonoformate inhibition suggest that the resulting apical Pi transport in the small intestine cannot be fully explained by the presence of NaPi2b, PiT1, or PiT2. We provide evidence of the presence of a new sodium-coupled Pi transporter that uses [Formula: see text] as the preferred substrate and is inhibited by phosphonoformate, and its expression correlates with Pi transport in all assayed conditions.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  NaPi2b; Pi deprivation; Pi transport; PiT1; PiT2; pH dependence; small intestine

Mesh:

Substances:

Year:  2017        PMID: 28232455     DOI: 10.1152/ajpgi.00244.2016

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  16 in total

1.  Kidney Disease Progression Does Not Decrease Intestinal Phosphorus Absorption in a Rat Model of Chronic Kidney Disease-Mineral Bone Disorder.

Authors:  Colby J Vorland; Annabel Biruete; Pamela J Lachcik; Shruthi Srinivasan; Neal X Chen; Sharon M Moe; Kathleen M Hill Gallant
Journal:  J Bone Miner Res       Date:  2019-11-15       Impact factor: 6.741

2.  Intestinal phosphate absorption: The paracellular pathway predominates?

Authors:  Matthew Saurette; R Todd Alexander
Journal:  Exp Biol Med (Maywood)       Date:  2019-02-14

3.  Phosphate and Cellular Senescence.

Authors:  Ming Chang Hu; Orson W Moe
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

4.  PF-06869206 is a selective inhibitor of renal Pi transport: evidence from in vitro and in vivo studies.

Authors:  Linto Thomas; Jianxiang Xue; Viktor N Tomilin; Oleh M Pochynyuk; Jessica A Dominguez Rieg; Timo Rieg
Journal:  Am J Physiol Renal Physiol       Date:  2020-08-03

Review 5.  Phosphate Metabolism in Health and Disease.

Authors:  Munro Peacock
Journal:  Calcif Tissue Int       Date:  2020-04-07       Impact factor: 4.333

6.  Expression of NaPi-IIb in rodent and human kidney and upregulation in a model of chronic kidney disease.

Authors:  Sarah E Motta; Pedro Henrique Imenez Silva; Arezoo Daryadel; Betül Haykir; Eva Maria Pastor-Arroyo; Carla Bettoni; Nati Hernando; Carsten A Wagner
Journal:  Pflugers Arch       Date:  2020-03-26       Impact factor: 3.657

7.  EOS789, a broad-spectrum inhibitor of phosphate transport, is safe with an indication of efficacy in a phase 1b randomized crossover trial in hemodialysis patients.

Authors:  Kathleen M Hill Gallant; Elizabeth R Stremke; Laurie L Trevino; Ranjani N Moorthi; Simit Doshi; Meryl E Wastney; Nozomi Hisada; Jotaro Sato; Yoshitaka Ogita; Naohisa Fujii; Yuya Matsuda; Takei Kake; Sharon M Moe
Journal:  Kidney Int       Date:  2020-10-31       Impact factor: 10.612

Review 8.  Intestinal phosphorus absorption: recent findings in translational and clinical research.

Authors:  Kathleen M Hill Gallant; Colby J Vorland
Journal:  Curr Opin Nephrol Hypertens       Date:  2021-07-01       Impact factor: 3.416

9.  Enhanced phosphate absorption in intestinal epithelial cell-specific NHE3 knockout mice.

Authors:  Jianxiang Xue; Linto Thomas; Sathish Kumar Murali; Moshe Levi; Robert A Fenton; Jessica A Dominguez Rieg; Timo Rieg
Journal:  Acta Physiol (Oxf)       Date:  2022-01-11       Impact factor: 7.523

10.  Effect of dietary phosphorus intake and age on intestinal phosphorus absorption efficiency and phosphorus balance in male rats.

Authors:  Colby J Vorland; Pamela J Lachcik; Loretta O Aromeh; Sharon M Moe; Neal X Chen; Kathleen M Hill Gallant
Journal:  PLoS One       Date:  2018-11-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.